| Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region N Ceran, R Turkoglu, I Erdem, A Inan, D Engin, H Tireli, P Goktas The Brazilian Journal of Infectious Diseases 15 (1), 52-59, 2011 | 124 | 2011 |
| Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis T Kalincik, EK Havrdova, D Horakova, G Izquierdo, A Prat, M Girard, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 458-468, 2019 | 90 | 2019 |
| Risk of secondary progressive multiple sclerosis: a longitudinal study A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, ... Multiple Sclerosis Journal 26 (1), 79-90, 2020 | 81 | 2020 |
| Autoantibodies to neuronal surface antigens in thyroid antibody-positive and-negative limbic encephalitis E Tüzün, E Erdağ, H Durmuş, T Brenner, R Türkoğlu, M Kürtüncü, B Lang, ... Neurology India 59 (1), 47-50, 2011 | 68 | 2011 |
| Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients E Tüzün, M Kürtüncü, R Türkoğlu, S İçöz, M Pehlivan, Ö Birişik, M Eraksoy, ... Journal of neuroimmunology 233 (1-2), 211-215, 2011 | 60 | 2011 |
| Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial T Chitnis, B Banwell, L Kappos, DL Arnold, K Gücüyener, K Deiva, ... The Lancet Neurology 20 (12), 1001-1011, 2021 | 53 | 2021 |
| Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: significant modulation of IL-17 and IL-23 M Kürtüncü, E Tüzün, R Türkoğlu, B Petek-Balcı, S İçöz, M Pehlivan, ... Cytokine 59 (2), 400-402, 2012 | 53 | 2012 |
| Natalizumab, fingolimod, and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis WZ Yeh, PA Widyastuti, A Van der Walt, J Stankovich, E Havrdova, ... Neurology 96 (24), e2989-e3002, 2021 | 51 | 2021 |
| Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica M Woodhall, A Çoban, P Waters, E Ekizoğlu, M Kürtüncü, E Shugaiv, ... Journal of the neurological sciences 335 (1-2), 221-223, 2013 | 51 | 2013 |
| Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study AL Nguyen, EK Havrdova, D Horakova, G Izquierdo, T Kalincik, ... Multiple sclerosis and related disorders 28, 235-243, 2019 | 49 | 2019 |
| Early clinical markers of aggressive multiple sclerosis CB Malpas, A Manouchehrinia, S Sharmin, I Roos, D Horakova, ... Brain 143 (5), 1400-1413, 2020 | 48 | 2020 |
| Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder A Kunchok, C Malpas, P Nytrova, EK Havrdova, R Alroughani, M Terzi, ... Multiple sclerosis and related disorders 38, 101868, 2020 | 40 | 2020 |
| Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders C Ulusoy, E Tüzün, M Kürtüncü, R Türkoğlu, G Akman-Demir, M Eraksoy International Journal of Neuroscience 122 (6), 284-289, 2012 | 38 | 2012 |
| Microbiota stratification identifies disease-specific alterations in neuro-Behçet’s disease and multiple sclerosis N Oezguen, N Yalcinkaya, CI Kücükali, M Dahdouli, EB Hollister, ... Clin Exp Rheumatol 37 (121), S58-66, 2019 | 35 | 2019 |
| Delay from treatment start to full effect of immunotherapies for multiple sclerosis I Roos, E Leray, F Frascoli, R Casey, JWL Brown, D Horakova, ... Brain 143 (9), 2742-2756, 2020 | 30 | 2020 |
| Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: multi-center, controlled trial S Ozakbas, R Turkoglu, Y Tamam, M Terzi, O Taskapilioglu, C Yucesan, ... Multiple sclerosis and related disorders 22, 70-76, 2018 | 30 | 2018 |
| Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease B Vural, E Şehitoğlu, F Çavuş, N Yalçınkaya, H Haytural, M Küçükerden, ... Journal of neuroimmunology 263 (1-2), 139-144, 2013 | 24 | 2013 |
| Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis M Gencer, E Akbayır, M Şen, E Arsoy, V Yılmaz, N Bulut, E Tüzün, ... Neurological Sciences 40, 1067-1070, 2019 | 23 | 2019 |
| Disease reactivation after cessation of disease-modifying therapy in patients with relapsing-remitting multiple sclerosis I Roos, C Malpas, E Leray, R Casey, D Horakova, EK Havrdova, ... Neurology 99 (17), e1926-e1944, 2022 | 19 | 2022 |
| Aquaporin-1 antibody in neuromyelitis optica patients E Tüzün, J Tzartos, E Ekizoğlu, C Stergiou, P Zisimopoulou, A Çoban, ... European Neurology 72 (5-6), 271-272, 2014 | 18 | 2014 |
ERDEM TÜZÜNİstanbul ÜniversitesiVerified email at istanbul.edu.tr
